التفاصيل البيبلوغرافية
| العنوان: |
The Changing Epidemiology of HIV-Infected Patients in the Intensive Care Unit. |
| المؤلفون: |
Akgün, Kathleen M., Pisani, Margaret, Crothers, Kristina |
| المصدر: |
Journal of Intensive Care Medicine; May2011, Vol. 26 Issue 3, p151-164, 14p |
| مصطلحات موضوعية: |
PNEUMOCYSTIS pneumonia, AGING, ARTIFICIAL respiration, CARDIOVASCULAR diseases, DRUG toxicity, HIV infections, HOSPITALS, INTENSIVE care units, LIFE skills, LIVER diseases, DEATH rate, NEUROLOGICAL disorders, PNEUMOTHORAX, RESPIRATORY insufficiency, SEPSIS, SERUM albumin, TUMORS, WEIGHT loss, COMORBIDITY, HIGHLY active antiretroviral therapy, DISEASE incidence, SEVERITY of illness index, IMMUNE reconstitution inflammatory syndrome, DISEASE risk factors |
| مستخلص: |
With the introduction of highly active antiretroviral therapy (HAART), HIV has become a chronic disease. As HIV-infected patients are aging, they are at increased risk for comorbid diseases. These non-AIDS related diseases account for a growing proportion of intensive care unit (ICU) admissions in HIV-infected patients in recent studies. HIV-infected patients still present to the ICU with HIV-related conditions such as Pneumocystis jirovecii pneumonia (PCP), but these conditions are becoming less common. Respiratory failure remains the most common indication for ICU admission. Immune reconstitution inflammatory response syndrome and toxicities related to HAART may also result in ICU admission. While ICU survival has improved since the earliest era of the HIV epidemic, hospital mortality for HIV-infected patients admitted to the ICU remains around 30%. Risk factors for ICU mortality include poor functional status, weight loss, more than one year between HIV diagnosis and ICU admission, lower serum albumin, higher severity of illness, need for mechanical ventilation, and respiratory failure-particularly if due to PCP and accompanied by pneumothorax. The impact of HAART on ICU outcomes is unclear. HAART administration in the ICU can be challenging due to limited delivery routes, concern for viral resistance and medication toxicities. There are no data to determine the safety or efficacy of HAART initiation in the ICU. Future studies are needed to address the role of age, associated comorbidities and impact of HAART on outcomes of HIV-infected patients admitted to the ICU [ABSTRACT FROM PUBLISHER] |
|
Copyright of Journal of Intensive Care Medicine is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder